Joel Richter

Joel Richter is a Professor of Molecular Medicine and the Arthur F. Koskinas Professor in Neuroscience the University of Massachusetts Chan Medical School. He obtained his PhD from Arizona State University and performed postdoctoral work at Purdue University. Dr. Richter has studied mRNA translation and processing for over four decades, held a MERIT award from the NIH, and was the founding director of the UMass Medical School’s NIH Center for Collaborative Research on Fragile X. Dr. Richter currently studies the molecular biology of Fragile X Syndrome and other neurological disorders.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Bolden Therapeutics

1 followers

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke.


Industries

Employees

1-10

Links